AI assistant
Sending…
EyePoint Pharmaceuticals, Inc. — Director's Dealing 2012
Dec 14, 2012
32254_dirs_2012-12-14_2dbba7f6-b231-4477-b934-ac4441ed2f01.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2012-12-14
Reporting Person: SAVAS PETER G (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-14 | Employee Stock Option (right to buy) | $2.14 | A | 30000 | Acquired | 2022-07-18 | Common Stock (30000) | Direct |
More from EyePoint Pharmaceuticals, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 22
Call Transcript
2026
Jun 9
Call Transcript
2026
Jun 3
Call Transcript
2026
May 26
Regulatory Filings
2026
May 14
Call Transcript
2026
May 6
Call Transcript
2026
May 6
Regulatory Filings
2026
May 6
Investor Presentation
2026
Apr 13
Call Transcript
2026
Mar 25